X4 Pharmaceuticals (XFOR) Operating Leases (2019 - 2025)
X4 Pharmaceuticals (XFOR) reported Operating Leases of $95,000 for Q3 2025, down 94.6% from $1.76 million a year earlier and down 88.3% from the prior quarter.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Operating Leases (2019 - 2025) Analysis & Trends
At the end of FY2024, X4 Pharmaceuticals posted Operating Leases of $1.41 million, down 46.0% from FY2023.
- Operating Leases has declined for three consecutive years, with a five-year compound annual growth rate of -6.0% (FY2019 to FY2024).
- By year, Operating Leases came in at $2.61 million in FY2023 (-27.5%), $3.6 million in FY2022 (-24.6%), $4.78 million in FY2021 (+6.5%) and $4.48 million in FY2020 (+133.8%).
- The Q3 2025 figure ranks as the lowest quarterly Operating Leases in data going back to Q1 2019.
- Year over year, Operating Leases has now declined in each of the last 15 quarters, with an average decline of 48.1% over the last eight quarters.
- The high point for year-over-year Operating Leases in five years was Q2 2021 (growth of 270.2%); the low point was Q3 2025 (a decline of 94.6%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $815,000 (Q2 2025), $1.11 million (Q1 2025) and $1.41 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | X4 Pharmaceuticals | 379.03 Mn | -319.65 Mn | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 95,000.00 |
| Jun 30, 2025 | 815,000.00 |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Sep 30, 2023 | 2.85 Mn |
| Jun 30, 2023 | 3.12 Mn |
| Mar 31, 2023 | 3.38 Mn |
| Dec 31, 2022 | 3.60 Mn |
| Sep 30, 2022 | 3.80 Mn |
| Jun 30, 2022 | 4.14 Mn |
| Mar 31, 2022 | 4.48 Mn |
| Dec 31, 2021 | 4.78 Mn |
| Sep 30, 2021 | 5.07 Mn |
| Jun 30, 2021 | 5.35 Mn |
| Mar 31, 2021 | 5.58 Mn |
| Dec 31, 2020 | 4.48 Mn |
API Access
X4 Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=XFOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();